Finding GAD: Early detection of β-cell injury

Endocrinology

Volumn 148, Issue 10, 2007, Pages 4568-4571

  Hinke, Simon A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNITY; DIABETES MELLITUS; DIABETOGENESIS; EARLY DIAGNOSIS; ENZYME ASSAY; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ONSET AGE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; REVIEW; STREPTOZOCIN DIABETES;

ALLOXAN; ANIMALS; BIOLOGICAL MARKERS; CELL DEATH; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GLUTAMATE DECARBOXYLASE; HUMANS; INSULIN-SECRETING CELLS; STREPTOZOCIN;

EID: 34748906510     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0861     Document Type: Review

References (40)

1. 2005 National Health Interview Survey. Atlanta, GA: National Center for Health Statistics, Centers for Disease Control
2. Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, Saydah SH, Williams DE, Geiss LS, Gregg EW 2006 Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care 29:1263-1268
3. Waldrop MA, Suckow AT, Marcovina SM, Chessler SD 2007 Release of Glutamate Decarboxylase-65 into the circulation by injured pancreatic islet β-cells. Endocrinology 148:4572-4578
4. Waldrop MA, Suckow AT, Hall TR, Hampe CS, Marcovina SM, Chessler SD 2006 A highly sensitive immunoassay resistant to autoantibody interference for detection of the diabetes-associated autoantigen glutamic acid decarboxylase 65 in blood and other biological samples. Diabetes Technol Ther 8:207-218
5. Sorenson RL, Garry DG, Brelje TC 1991 Structural and functional considerations of GABA in islets of Langerhans. β-Cells and nerves. Diabetes 40:1365-1374
6. Braun M, Wendt A, Birnir B, Broman J, Eliasson L, Galvanovskis J, Gromada J, Mulder H, Rorsman P 2004 Regulated exocytosis of GABA-containing synaptic-like microvesicles in pancreatic β-cells. J Gen Physiol 123:191-204
7. B receptors contribute to the modulation of glucose-stimulated insulin secretion in pancreatic β-cells. Diabetologia 45:242-252
8. A receptor subtype mRNA in human pancreatic tissue. FEBS Lett 346:257-262
9. Mally MI, Cirulli V, Otonkoski T, Soto G, Hayek A 1996 Ontogeny and tissue distribution of human GAD expression. Diabetes 45:496-501
10. Chessler SD, Lernmark A 2000 Alternative splicing of GAD67 results in the synthesis of a third form of glutamic-acid decarboxylase in human islets and other non-neural tissues. J Biol Chem 275:5188-5192
11. Dirkx Jr R, Thomas A, Li L, Lernmark A, Sherwin RS, De Camilli P, Solimena M 1995 Targeting of the 67-kDa isoform of glutamic acid decarboxylase to intracellular organelles is mediated by its interaction with the NH2-terminal region of the 65-kDa isoform of glutamic acid decarboxylase. J Biol Chem 270:2241-2246
12. Lernmark A 1996 Glutamic acid decarboxylase: gene to antigen to disease. J Intern Med 240:259-277
13. Kaufman DL, Erlander MG, Clare-Salzler M, Atkinson MA, Maclaren NK, Tobin AJ 1992 Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 89:283-292
14. Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, Eizirik DL 2005 Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54(Suppl 2):S97-S107
15. Donath MY, Storling J, Maedler K, Mandrup-Poulsen T 2003 Inflammatory mediators and islet β-cell failure: a link between type 1 and type 2 diabetes. J Mol Med 81:455-470
16. Smismans A, Ling Z, Pipeleers D 1996 Damaged rat β cells discharge glutamate decarboxylase in the extracellular medium. Biochem Biophys Res Commun 228:293-297
17. Hao W, Daniels T, Pipeleers DG, Smismans A, Reijonen H, Nepom GT, Lernmark A 1999 Radioimmunoassay for glutamic acid decarboxylase-65. Diabetes Technol Ther 1:13-20
18. 14C] streptozotocin and its distribution and excretion in the rat. Biochem J 142:673-683
19. Thulesen J, Orskov C, Holst JJ, Poulsen SS 1997 Short-term insulin treatment prevents the diabetogenic action of streptozotocin in rats. Endocrinology 138:62-68
20. Rui M, Hampe CS, Wang C, Ling Z, Gorus FK, Lernmark A, Pipeleers DG, De Pauw PE 2007 Species and epitope specificity of two 65 kDa glutamate decarboxylase time-resolved fluorometric immunoassays. J Immunol Methods 319:133-143
21. Shapiro AM, Hao EG, Lakey JR, Yakimets WJ, Churchill TA, Mitlianga PG, Papadopoulos GK, Elliott JF, Rajotte RV, Kneteman NM 2001 Novel approaches toward early diagnosis of islet allograft rejection. Transplantation 71:1709-1718
22. The Diabetes Control and Complications Trial Research Group 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329:977-986
23. Shah SC, Malone JI, Simpson NE 1989 A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. N Engl J Med 320:550-554
24. Baggio LL, Drucker DJ 2006 Therapeutic approaches to preserve islet mass in type 2 diabetes. Annu Rev Med 57:265-281
25. Itoh N, Hanafusa T, Miyazaki A, Miyagawa J-i, Yamagata K, Yamamoto K, Waguri M, Imagawa A, Tamura S, Inada M, Kawata S, Tarui S, Kono N, Matsuzawa Y 1993 Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J Clin Invest 92:2313-2322
26. Mathis D, Vence L, Benoist C 2001 β-Cell death during progression to diabetes. Nature 414:792-798
27. Pihoker C, Gilliam LK, Hampe CS, Lernmark A 2005 Autoantibodies in diabetes. Diabetes 54(Suppl 2):S52-S61
28. Skyler JS 2007 Prediction and prevention of type 1 diabetes: progress, problems, and prospects. Clin Pharmacol Ther 81:768-771
29. Gale EA, Bingley PJ, Emmett CL, Collier T 2004 European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet 363:925-931
30. Skyler JS, Krischer JP, Wolfsdorf J, Cowie C, Palmer JP, Greenbaum C, Cuthbertson D, Rafkin-Mervis LE, Chase HP, Leschek E 2005 Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial-Type 1. Diabetes Care 28:1068-1076
31. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, Lakey JR, Shapiro AM 2005 Five-year follow-up after clinical islet transplantation. Diabetes 54:2060-2069
32. Emamaullee JA, Shapiro AM 2006 Interventional strategies to prevent β-cell apoptosis in islet transplantation. Diabetes 55:1907-1914
33. Prentki M, Nolan CJ 2006 Islet β-cell failure in type 2 diabetes. J Clin Invest 116:1802-1812
34. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC 2003 β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110
35. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV 1997 Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20:537-544
36. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M 2001 Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350
37. Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman RR 2006 Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 368:1096-1105
38. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM 2002 Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403
39. Pipeleers D, Hoorens A, Marichal-Pipeleers M, Van de Casteele M, Bouwens L, Ling Z 2001 Role of pancreatic β-cells in the process of β-cell death. Diabetes 50(Suppl 1):S52-S57
40. Hui H, Dotta F, Di Mario U, Perfetti R 2004 Role of caspases in the regulation of apoptotic pancreatic islet β-cells death. J Cell Physiol 200:177-200